FDA just approved updated labeling for three more menopause hormone therapy (MHT) products, additionally we are also working to speed up production so that more women can get the treatments they need. This is part of our commitment to women’s health and directly supports a recent Executive Order signed by President Trump on October 19, 2026, that focused on advancing health outcomes for women at every stage of life. hhs.gov/press-room/fda-advan…
Image from U.S. FDA (@FDA)

Oct 30, 2026 · 3:54 PM UTC

7
9
4
32
13,662
RelevantRecentLikes
Good move. That old warning label scared a lot of women away from hormone therapy. For healthy women under 60 or within 10 years of menopause, the benefits outweigh the risks for hot flashes and bone protection for many.
1
237
Deramiocel is waiting, cucks
225
I had a had some luck and found a 2 month supply after going without for 2 months. Now they are out of stock AGAIN. This needs to be handled for consistent care for women.
3
And yet the boys with DMD still wait on approval for an option when they currently have none…do better FDA.
1
228
Thank you. The press statement said the FDA isn’t aware of product shortages. There are shortages happening all over the nation for products from numerous companies. This is life or death for many women.
190
Load more replies